Oct 20, 2021 | Cancer Center News
Photo of Shannon Sirk. Urbana, Ill. – Therapeutic antibodies have revolutionized the treatment of many diseases, including cancer. However, these drugs can be prohibitively expensive and are not an option for every patient. Shannon Sirk, Cancer Center at Illinois...
Sep 22, 2021 | Cancer Center News
Photo of Nicholas Wu. Urbana, Ill. – Nicholas Wu, assistant professor of biochemistry, was recently named an associate member of the Cancer Center at Illinois. Previously focusing on viruses such as influenza and COVID-19 in his research, Wu is eager to expand his...
Jul 8, 2021 | Cancer Center News
Hailey Knox, ChemistryTissue Microenvironment (TiMe) Program, 2018 Cohort Where are you working now? I am currently working as a postdoctoral scholar with Professors Dennis Dougherty and Henry Lester at the California Institute of Technology. What are you currently...
Jun 10, 2021 | Cancer Center News
Harpal Singh, BioengineeringCancer Scholar, 2017 Cohort Where are you working now? I am a senior about to graduate this May. Following graduation, I will be working in a Biologics rotational program with the company Catalent Pharma. What are you currently researching?...
May 4, 2021 | Cancer Center News
Urbana, Ill. – A team from the University of Illinois Urbana-Champaign’s Grainger College of Engineering and Mayo Clinic have developed a new technique for creating “microcancer” cell cultures. It allows researchers to form hundreds of microcancers in a...
Nov 3, 2020 | Cancer Center News
Although small molecule drugs and antibodies continue to be the standard for cancer treatment, a new class of therapeutics — lasso peptides — may prove effective, especially for disease targets that thwart traditional approaches. Combining the power of antibodies and...
Oct 12, 2020 | Cancer Center News
Matthew Boudreau, a chemistry PhD candidate in the Cancer Center at Illinois (CCIL) Deputy Director Paul Hergenrother’s lab, has been awarded the prestigious F99/K00 grant from the National Cancer Institute (NCI). Boudreau’s research has centered around a novel...
Oct 1, 2020 | Cancer Center News
Researchers affiliated with the Cancer Center at Illinois discovered a novel small molecule compound that is now the subject of a new global licensing agreement between the pharmaceutical company Bayer AG and the cancer drug development company Systems Oncology LLC....
Jun 18, 2020 | Cancer Center News
The Cancer Center at Illinois at the University of Illinois at Urbana-Champaign is supporting three new cancer research projects through its planning grant initiative. Recipients will each receive up to $25,000 to spark innovative research projects that have promise...
Nov 20, 2019 | Cancer Center News
The team includes, from left, graduate student Emily Geddes, pathobiology professor Gee Lau, chemistry professor Paul Hergenrother, postdoctoral researcher Hyang Yeon Lee, and postdoctoral researcher Erica Parker. Paul Hergenrother, professor of chemistry,...
May 21, 2018 | Cancer Center News
Illinois professor Andrew Smith, right, and graduate student Mohammad Zahid. With targeted drug and gene therapies, finding the target cells is only half the battle. Once these agents reach a cell’s surface, they still have to get inside and do their job. University...
Mar 3, 2018 | Cancer Center News
Image of T-Cell. T cell receptor (TCR) gene therapy can target the immune system to solid tumors in ways CAR-T cells can’t match, but the field is still looking for a clear success. Last September, GlaxoSmithKline took over one of Adaptimmune Therapeutics’...
